« Return to News | Technology Solutions

BioClinica, Mirada partner for molecular image analysis

Monday, April 2, 2012 06:35 AM

Through a newly formed partnership, BioClinica, a global provider of clinical trial management solutions, will integrate Oxford-based Mirada Medical's XD3 software solution into its imaging core lab technology to enhance its PET capabilities and expertise for molecular imaging trials.

Mirada’s integrated software will provide tools and efficient workflows for the quantification and tracking of findings for major modalities including PET, CT, MR and MR/PET. Once XD2 is integrated into BioClinica’s BioPACS and BioREAD technologies, the imaging workflow and processing programs’ will be capable of helping trial sponsors harness the superior imaging results that are achievable through PET scans and multiple modalities technology.

Through the partnership, BioClinica's PET image processing capabilities will extend oncology clinical trials with support for the following features:

  • Enhanced capabilities for PERCIST tumor response assessment criteria
  • Normalization of uptake by body weight, lean body mass or body surface area for SUV measurements
  • Registration and fusion capabilities between PET, CT and MR
  • Customizable workflow and user interface to provide flexibility in the independent read design

Furthermore, as part of this partnership, Mirada will present at BioClinica's 2012 User Conference—which is designed to help BioClinica imaging core lab customers and eClinical solution users discover new ways to run faster, more efficient clinical trials.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.